Interventional Cardiology and Peripheral Vascular Devices Market
IMARC Group, a leading market research company, has recently releases report titled “Interventional Cardiology and Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the global interventional cardiology and peripheral vascular devices market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big are the interventional cardiology and peripheral vascular devices market?
The global interventional cardiology and peripheral vascular
devices market size reached US$ 23.08 Billion in 2022. Looking forward, IMARC
Group expects the market to reach US$ 38.28 Billion by 2028, exhibiting a
growth rate (CAGR) of 8.10% during 2023-2028.
What are Interventional
Cardiology and Peripheral Vascular Devices?
Interventional cardiology and peripheral vascular devices are medical
tools used in minimally invasive procedures for the treatment of heart and
vascular diseases. In interventional cardiology, these devices are employed to
diagnose and treat conditions like coronary artery disease, heart valve
disorders, and congestive heart failure. Common devices include stents,
catheters, and balloons used in angioplasty procedures.
In terms of peripheral vascular
devices, they are used to treat diseases in blood vessels outside of the heart
and brain, such as peripheral artery disease and deep vein thrombosis. These
devices include angioplasty balloons, stents, catheters, grafts, and vena cava
filters.
Request for a sample report or buy full report: https://www.imarcgroup.com/interventional-cardiology-peripheral-vascular-devices-market/requestsample
What are the growth prospects and trends in the interventional cardiology and peripheral vascular devices industry?
The increasing
prevalence of cardiovascular diseases (CVDs) represents one of the key factors
driving the growth of the market across the globe. As per the World Health
Organization, CVDs are the number one cause of death globally. This is leading
to the rising demand for effective and minimally invasive treatment methods,
which is increasing the need for these devices. The growing awareness among
patients and healthcare providers about the benefits of minimally invasive
procedures is contributing to the growth of the market across the globe. These
procedures often result in less pain, shorter hospital stays, and faster
recoveries compared to traditional surgeries, thus making them a preferred
choice.
Moreover, the rise in clinical trials and research and development (R&D)
activities by key market players for new product development, and regulatory
approvals of these products are propelling the market growth. Other factors,
such as advancements in technology, rising geriatric population, increasing
healthcare expenditure, and improving health infrastructure, are creating a
positive outlook for the market across the globe.
What
is included in market segmentation?
The report has segmented
the market into the following categories:
Market Breakup by Product
Type:
·
Inferior Vena Cava (IVC)
Filters
·
Plaque Modification
Devices
·
Hemodynamic Flow
Alteration Devices
·
Accessories
·
Angioplasty Balloons
·
Angioplasty Stents
·
Angioplasty Catheters
·
Endovascular Aneurysm
Repair Stent Grafts
Market Breakup by
Indication:
·
Coronary Intervention
·
Peripheral Arterial
Disease
Market Breakup by Age
Group:
·
Geriatric
·
Adults
·
Paediatric
Market Breakup by End
User:
·
Hospitals
·
Ambulatory Surgical
Centers
·
Others
Market Breakup by Region:
·
North America (United
States, Canada)
·
Asia Pacific (China,
Japan, India, South Korea, Australia, Indonesia, Others)
·
Europe (Germany, France,
United Kingdom, Italy, Spain, Russia, Others)
·
Latin America (Brazil,
Mexico, Others)
·
Middle East and Africa
Who are the key players operating in the industry?
The report covers the
major market players including:
·
Abbott Laboratories
·
B. Braun Melsungen AG
·
Becton Dickinson and
Company
·
Biotronik SE & Co.
KG
·
Boston Scientific
Corporation
·
Cook Group Incorporated
·
Cordis Corporation
·
Koninklijke Philips N.V.
·
Medtronic plc.
·
Teleflex Incorporated
·
Terumo Corporation
Ask Analyst for Customization and
Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=7542&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading
market research company that offers management strategy and market research
worldwide. We partner with clients in all sectors and regions to identify their
highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products
include major market, scientific, economic and technological developments for
business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology,
advanced materials, pharmaceuticals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of the company’s
expertise.
Our offerings include
comprehensive market intelligence in the form of research reports, production
cost reports, feasibility studies, and consulting services. Our team, which
includes experienced researchers and analysts from various industries, is
dedicated to providing high-quality data and insights to our clientele, ranging
from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn,
NY 11249, USA
USA: +1-631-791-1145 |
Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter:
@imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
Comments
Post a Comment